The ETS-family transcription factor PU.1 is expressed in hematopoietic
tissues, with significant levels of expression in the monocytic and B
lymphocytic lineages, PU.1 is identical to the Spi-1 proto-oncogene w
hich is associated with the generation of spleen focus-forming virus-i
nduced erythroleukemias, An extensive body of in vitro gene regulatory
studies has implicated PU.1 as an important, versatile regulator of B
lymphoid-and myeloid-specific genes, The first half of the review is
designed to coalesce data generated from studies examining the two PU.
1 ''knockout'' animals, which have prompted a reevaluation of the prop
osed function of PU.1 during hematopoiesis. During hematopoiesis, PU.1
is required for development along the lymphoid and myeloid lineages b
ut needs to be downregulated during erythropoiesis, These unique funct
ional characteristics of PU.1 will be exemplified by contrasting the f
unction of PU.1 with other transcription factors required during fetal
hematopoiesis, The second half of this review will reexamine the func
tional characteristics of PU.1 deduced from traditional biochemical an
d transactivation assays in light of recent experiments examining the
functional behavior of PU.1 in an embryonic stem cell in vitro differe
ntiation system, Working models of how PU.1 regulates promoter and enh
ancer regions in the B cell and myeloid lineage will be presented and
discussed.